-
Innovation Ranking
Innovation Ranking – E Ink Holdings Inc
E Ink Holdings Inc (E Ink) is a provider of electronic paper display solutions. It offers consumer and industrial products including eReaders and mobile phones, electronic shelf labels, promotional signs, and smartwatches. E Ink’s electronic paper display products are applied in electronic books, segment displays, and electronic readers. It provides products under the brand name of E Ink, and Think Pearl. The company’s thin-film transistor panels and modules are used in reading and writing products, mobile and wearables devices, retail,...
-
Innovation Ranking
Innovation Ranking – Toyo Ink SC Holdings Co Ltd
Toyo Ink SC Holdings Co Ltd (Toyo Ink) is a chemical manufacturer and distributor. The company provides services such as printing and information business, a packaging business, polymer and coating business, color and functional materials business and others. Toyo Ink’s product portfolio includes printing inks, industrial chemicals, offset inks, inkjet inks, gravure inks, gravure solvents, screen inks, flexographic inks, can coatings, adhesives, pigments, high function pigments and plastic colorants, and printing equipment, and systems. The company has operations in France,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INK Acute Myeloid Leukemia in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INK Acute Myeloid Leukemia in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INK Acute Myeloid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNTY-101 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNTY-101 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNTY-101 in Primary Mediastinal B-Cell Lymphoma Drug Details: CNTY-101...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNTY-101 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNTY-101 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNTY-101 in Marginal Zone B-cell Lymphoma Drug Details: CNTY-101...
-
Company Insights
Innovation and Patenting activity of E Ink Holdings Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of E Ink Holdings Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of Toyo Ink SC Holdings Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Toyo Ink SC Holdings Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNTY-101 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNTY-101 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNTY-101 in Follicular Lymphoma Drug Details: CNTY-101 (CAR-iNK cell therapy) is under...
-
Product Insights
Neurological Diagnostic and Monitoring Equipment Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Neurological Diagnostic and Monitoring Equipment Pipeline Market Report Overview The Neurological Diagnostic and Monitoring Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Electroencephelographs (EEG) ·       ICP Monitoring Devices ·       Electrical Activity Testing ·       ...